Evaluation of the effects of a single dose of Cannabidiol on attention and memory in people with Obsessive Compulsive Disorder
- Conditions
- Obsessive-compulsive disorderF02.463.425.540.739
- Registration Number
- RBR-5dbqvhd
- Lead Sponsor
- Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Intervention Group: 17 patients diagnosed with Obsessive Compulsive Disorder will be included according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, 5th edition, revised text (DSM-5-TR); of both sexes; aged 18 or over; and who do not have any other psychiatric comorbidity
Control Group: 17 subjects will be included without any current or previous psychiatric disorder; of both sexes; and who are 18 years of age or older
Intervention Group: Patients who present adverse reactions to the use of the substance or those who do not complete the experimental tasks that make up the study will be excluded.
Control Group: Subjects who present adverse reactions to the use of the substance or those who do not complete the experimental tasks that make up the study will be excluded.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction and/or elimination of attention bias and implicit memory that will be assessed using the Emotional Stroop, Dot Probe and Implicit Association Test instruments, all three instruments were personalized for Obsessive Compulsive Disorder.<br>
- Secondary Outcome Measures
Name Time Method Decrease in anxiety and other aspects of mood, assessed using the Analog Mood Scale (VAMS), and the presence or absence of side effects, assessed using the Society's Clinical Investigation Committee's Scale for Side Effects of Psychotropic Drugs Scandinavian Institute of Psychopharmacology (UKU).